2024 HCPCS Code Q4074
Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
TAGS: inhalation through micrograms final administered
| Short Description | Iloprost non-comp unit dose |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2010 |
| HCPCS Code Added Date | January 01, 2010 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q0169 - Promethazine hcl 12.5mg oral
- Q0173 - Trimethobenzamide hcl 250mg
- Q0174 - Thiethylperazine maleate10mg
- Q0175 - Perphenazine 4mg oral
- Q0177 - Hydroxyzine pamoate 25mg
- Q0180 - Dolasetron mesylate oral
- Q0181 - Unspecified oral anti-emetic
- Q0220 - Tixagev and cilgav, 300mg
- Q0221 - Tixagev and cilgav, 600mg
- Q0222 - Bebtelovimab 175 mg
- Q0224 - Inj, pemivibart, 4500 mg
- Q0235 - Inj, monoclon antibody, 1 mg
- Q0237 - Inj, tocilizumab-anoh, hospi
- Q0239 - Bamlanivimab-xxxx
- Q0240 - Casirivi and imdevi 600 mg
- Q0243 - Casirivimab and imdevimab
- Q0244 - Casirivi and imdevi 1200 mg
- Q0245 - Bamlanivimab and etesevima
- Q0247 - Sotrovimab
- Q0249 - Tocilizumab for covid-19
